Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy OptiNose stock

Learn how to easily invest in OptiNose stock.

+ $0.18 ( + 5.17%)

OptiNose is a drug manufacturers-specialty & generic business based in the US. OptiNose shares (OPTN) are listed on the NASDAQ and all prices are listed in US Dollars. OptiNose employs 189 staff and has a trailing 12-month revenue of around $79.7 million.

How to buy shares in OptiNose

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – OPTN – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

OptiNose stock price (NASDAQ: OPTN)

Use our graph to track the performance of OPTN stocks over time.

OptiNose shares at a glance

Information last updated 2022-09-24.
Latest market close$3.66
52-week range$1.46 - $4.30
50-day moving average $3.66
200-day moving average $2.72
Wall St. target price$7.75
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-1.28

Buy OptiNose shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 7 of 7
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, ETFs, Cryptocurrency
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Stocks, ETFs, Cryptocurrency
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$125 - $625
when you open and fund an account with $25,000 - $250,000+
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.
Stocks, Options, ETFs
Customize your trade platform or build your own Deep tools, charts and screens Analyzers to help you study before you trade

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy OptiNose stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

OptiNose price performance over time

Historical closes compared with the close of $3.66 from 2022-09-30

1 week (2022-09-23) 4.87%
1 month (2022-09-02) 1.39%
3 months (2022-07-01) 0.55%
6 months (2022-03-29) 41.86%
1 year (2021-10-01) 20.00%
2 years (2020-10-02) -7.81%
3 years (2019-10-02) 6.48
5 years (2017-09-28) N/A

OptiNose financials

Revenue TTM $79.7 million
Gross profit TTM $65.5 million
Return on assets TTM -29.28%
Return on equity TTM -1050.5%
Profit margin -97.23%
Book value $0.13
Market capitalisation $290.6 million

TTM: trailing 12 months

OptiNose share dividends

We're not expecting OptiNose to pay a dividend over the next 12 months.

OptiNose share price volatility

Over the last 12 months, OptiNose's shares have ranged in value from as little as $1.455 up to $4.3. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while OptiNose's is -0.0785. This would suggest that OptiNose's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, OptiNose has bucked the trend.

OptiNose overview

OptiNose, Inc. , a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps, as well as is in Phase IIIb clinical trial for treatment of chronic sinusitis; and Onzetra Xsail, a powder EDS device. It is also developing OPN-019 that combines liquid EDS device with an antiseptic. The company has a license agreement with Currax Pharmaceuticals LLC for the commercialization of Onzetra Xsail; and Inexia Limited to develop, manufacture, import, and sale products containing orexin receptor agonist and/or orexin receptor positive modulator molecules for the treatment, diagnosis, or prevention of human diseases or conditions associated primarily with orexin receptor agonism and orexin receptor positive modulation. OptiNose, Inc. was founded in 2000 and is headquartered in Yardley, Pennsylvania.

Frequently asked questions

What percentage of OptiNose is owned by insiders or institutions?
Currently 9.008% of OptiNose shares are held by insiders and 75.327% by institutions.
How many people work for OptiNose?
Latest data suggests 189 work at OptiNose.
When does the fiscal year end for OptiNose?
OptiNose's fiscal year ends in December.
Where is OptiNose based?
OptiNose's address is: 1020 Stony Hill Road, Yardley, PA, United States, 19067
What is OptiNose's ISIN number?
OptiNose's international securities identification number is: US68404V1008
What is OptiNose's CUSIP number?
OptiNose's Committee on Uniform Securities Identification Procedures number is: 68404V100

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site